Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo

British Journal of Dermatology

Volumn 167, Issue 2, 2012, Pages 314-323

  Imran, M ^a   Laddha, N C ^a   Dwivedi, M ^a   Mansuri, M S ^a   Singh, J ^b   Rani, R ^b   Gokhale, R S ^b,c   Sharma, V K ^d   Marfatia, Y S ^a   Begum, R ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN E; INTERLEUKIN 4; MESSENGER RNA; RNA;

ARTICLE; CASE CONTROL STUDY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; INDIA; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

ADOLESCENT; AGE OF ONSET; CASE-CONTROL STUDIES; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INDIA; INTERLEUKIN-4; INTRONS; LINKAGE DISEQUILIBRIUM; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; VITILIGO;

EID: 84864401342     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11000.x     Document Type: Article

References (43)

1. Taieb A, Picardo M,; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35.
2. Ortonne JP, Bose SK,. Vitiligo: where do we stand? Pigment Cell Res 1993; 8: 61-72.
3. Tamer E, Ilhan MN, Polat M, et al. Prevalence of skin diseases among pediatric patients in Turkey. J Dermatol 2008; 35: 413-18.
4. Shajil EM, Chatterjee S, Agrawal D, et al. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Ind J Exp Biol 2006; 44: 526-39.
5. Kemp EH, Waterman EA, Weetman AP, et al. Immunological pathomechanisms in vitiligo. Expert Rev Mol Med 2001; 23: 1-22.
6. Spritz RA,. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 2010; 2: 78.
7. Nares S,. The genetic relationships to periodontal disease. Periodontol 2000 2003; 32: 36-49.
8. Kornman KS, di Giovine FS,. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol 1998; 3: 327-8.
9. Rocken M, Racke M, Shevach EM,. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 1996; 17: 225-31.
10. Salgame P, Abrams J, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279-82.
11. Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140: 4193-8.
12. Kidd P,. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003; 8: 223-46.
13. Wong CK, Ho CY, Li EK, et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589-93.
14. Chiang CH, Tang YC, Lin MW, et al. Association between the IL-4 promoter polymorphisms and asthma or severity of hyperresponsiveness in Taiwanese. Respirology 2007; 12: 42-8.
15. Rosenwasser LJ, Klemm DJ, Dresback JK, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25: 74-8.
16. Luoni G, Verra F, Arca B, et al. Antimalarial antibody levels and IL-4 polymorphism in the Fulani of West Africa. Genes Immun 2001; 2: 411-14.
17. Nakashima H, Miyake K, Inoue Y, et al. Association between IL4 genotype and IL-4 production in the Japanese population. Genes Immun 2002; 3: 107-9.
18. Shi YY, He L,. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-8.
19. Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (). Cell Res 2009; 19: 519-23.
20. Barrett JC, Fry B, Maller J, Dally MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
21. Faul F, Erdfelder E, Lang AG, et al. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91.
22. Shajil EM, Agrawal D, Vagadia K, et al. Vitiligo: clinical profiles in Vadodara, Gujarat. Ind J Dermatol 2006; 51: 100-4.
23. Shajil EM,. Biochemical basis and genetic association studies of selected single nucleotide polymorphisms in catalase and glutathione peroxidase genes in vitiligo. PhD thesis, The M.S. University of Baroda, Vadodara, India, 2007.
24. Singh A, Sharma P, Kar HK, et al. HLA alleles and amino acid signatures of the peptide binding pockets of HLA molecules in vitiligo. J Invest Dermatol 2012; 132: 124-34.
25. Dwivedi M, Laddha NC, Imran M, et al. Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation. Pigment cell Melanoma Res 2011; 24: 737-40.
26. Dwivedi M, Gupta K, Gulla KC, et al. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo. Br J Dermatol 2009; 161: 63-9.
27. Dwivedi M, Laddha NC, Shajil EM, et al. The ACE gene I/D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population. Pigment cell Melanoma Res 2008; 21: 407-8.
28. Laddha NC, Dwivedi M, Shajil EM, et al. Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population. J Dermatol Sci 2008; 49: 260-2.
29. Pehlivan S, Ozkinay F, Alper S, et al. Association between IL4 (-590), ACE (I)/(D), CCR5 (Δ32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo. Eur J Dermatol 2009; 19: 126-8.
30. Hosseini-Farahabadi S, Tavakkol-Afshari J, Rafatpanah H, et al. Association between the polymorphisms of IL-4 gene promoter (-590C>T), IL-13 coding region (R130Q) and IL-16 gene promoter (-295T>C) and allergic asthma. Iran J Allergy Asthma Immunol 2007; 6: 9-14.
31. Yu HH, Liu PH, Lin YC, et al. Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 2010; 19: 1219-28.
32. Moreno O, González CI, Saaibi DL, et al. Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis. J Rheumatol 2007; 34: 36-42.
33. Chen X, Xu J, Chen Z, et al. Interferon-gamma +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. Eur J Haematol 2007; 79: 191-7.
34. Heward JM, Nithiyananthan R, Allahabadia A, et al. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metabol 2001; 86: 3861-3.
35. Cantagrel A, Navaux F, Loubet-Lescoulie P, et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999; 42: 1093-100.
36. Wu MC, Huang CM, Tsai JJ, et al. Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003; 12: 21-5.
37. Bid HK, Konwar R, Agrawal CG, et al. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Ind J Med Sci 2008; 62: 259-66.
38. Kim BS, Kang JH, Park SM, et al. Association of -589 and -33 SNP in IL4 promoter with asthmatics and its mRNA production. Am J Respir Crit Care Med 2010; 181: A1333.
39. De Guia RM, Ramos JDA,. The -590C/T IL4 single-nucleotide polymorphism as a genetic factor of atopic allergy. Int J Mol Epidemiol Genet 2010; 1: 67-73.
40. Perfetti L, Cespa M, Nume A, et al. Prevalence of atopy in vitiligo: a preliminary report. Dermatologica 1991; 182: 218-20.
41. Behl PN, Agarwal A, Srivastava G,. Etiopathogenesis of vitiligo: are we dealing with an environmental disorder? Indian J Dermatol Venereol Leprol 1999; 65: 161-7.
42. Thepen T, Langeveld-Wildschut EG, Bihari IC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. Allergy Clin Immunol 1996; 97: 828-37.
43. Ochel M, Vohr HW, Pfeiffer C, et al. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991; 146: 3006-11.